Profile picture

Doctor Miguel Sobral Domingues

Western Lisbon Hospital Centre, EPE, Lisbon (Portugal)
Follow
Biography
Cardiology resident in Hospital de Santa Cruz, Lisboa
Logo ESC

Contributor content

Prognostic value of early ScvO₂ and pCO₂ gap kinetics and normalisation in patients with cardiogenic shock: a new management target?
Presentation
Prognostic value of early ScvO₂ and pCO₂ gap kinetics and normalisation in patients with cardiogenic shock: a new management target?
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Presentation
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Presentation
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Effect of apolipoprotein B reduction on major adverse cardiovascular events in randomized controlled trials of triglyceride-lowering therapies: systematic review and exploratory meta-regression
Presentation
Effect of apolipoprotein B reduction on major adverse cardiovascular events in randomized controlled trials of triglyceride-lowering therapies: systematic review and exploratory meta-regression
Prognostic value of stress perfusion CMR: a real-world single-center experience in portuguese patients with known coronary artery disease
Presentation
Prognostic value of stress perfusion CMR: a real-world single-center experience in portuguese patients with known coronary artery disease
Prognostic value of stress perfusion CMR in patients without known coronary artery disease: a real-world single-center experience
Presentation
Prognostic value of stress perfusion CMR in patients without known coronary artery disease: a real-world single-center experience
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Presentation
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Presentation
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Prognostic value of early ScvO2 and pCO2 gap kinetics and normalization in patients with cardiogenic shock: a new management target?
Presentation
Prognostic value of early ScvO2 and pCO2 gap kinetics and normalization in patients with cardiogenic shock: a new management target?
Prognostic value of stress perfusion cardiac magnetic resonance: real-world evidence from a large Portuguese cohort
Presentation
Prognostic value of stress perfusion cardiac magnetic resonance: real-world evidence from a large Portuguese cohort